Scimeca Dario's Form 4 filing
Precision Biosciences Inc (DTIL) · filed Jun 9, 2022
- Accession no.
- 0001209191-22-035410
- Filed
- Jun 9, 2022
- Trade date
- Jun 7-8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $20.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Scimeca DarioCIK 0001779581 | Officer (General Counsel and Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2022 | Common Stock | MOption exerciseAcquired | +22,727 | –F2 | – | 33,300 | Direct | |
| Jun 7, 2022 | Common Stock | MOption exerciseAcquired | +9,047 | –F2 | – | 42,347 | Direct | |
| Jun 8, 2022 | Common Stock | SSaleDisposed | −9,833 | $2.06 | −$20,255.98 | 32,514 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2022 | Common Stock | MOption exerciseDisposed | −22,727 | $0.00 | $0 | 22,727 | Direct | |
| Jun 7, 2022 | Common Stock | MOption exerciseDisposed | −9,047 | $0.00 | $0 | 18,089 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each RSU represents a contingent right to receive one share of the Company's Common Stock.
Referenced by the price of 2 transactions in Table I.